William Blair Has Pessimistic Outlook of Zoetis Q1 Earnings

Zoetis Inc. (NYSE:ZTS) – Equities research analysts at William Blair dropped their Q1 2025 EPS estimates for shares of Zoetis in a note issued to investors on Friday, January 31st. William Blair analyst B. Vazquez now forecasts that the company will post earnings of $1.38 per share for the quarter, down from their previous estimate of $1.45. The consensus estimate for Zoetis’ current full-year earnings is $5.90 per share. William Blair also issued estimates for Zoetis’ Q2 2025 earnings at $1.63 EPS, Q3 2025 earnings at $1.66 EPS, Q4 2025 earnings at $1.52 EPS, FY2025 earnings at $6.20 EPS, Q1 2026 earnings at $1.54 EPS, Q2 2026 earnings at $1.82 EPS, Q3 2026 earnings at $1.86 EPS, Q4 2026 earnings at $1.70 EPS and FY2026 earnings at $6.92 EPS.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.58 EPS for the quarter, beating the consensus estimate of $1.46 by $0.12. The business had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The company’s revenue was up 11.6% on a year-over-year basis. During the same period in the previous year, the business earned $1.36 earnings per share.

Other analysts have also issued reports about the company. Leerink Partners started coverage on Zoetis in a research note on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price objective on the stock. JPMorgan Chase & Co. raised their price target on shares of Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Leerink Partnrs upgraded shares of Zoetis to a “strong-buy” rating in a research report on Monday, December 2nd. Stifel Nicolaus decreased their target price on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research note on Tuesday, January 7th. Finally, Morgan Stanley lowered their price target on shares of Zoetis from $248.00 to $243.00 and set an “overweight” rating for the company in a report on Wednesday, January 29th. One analyst has rated the stock with a hold rating, ten have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Zoetis has a consensus rating of “Buy” and a consensus target price of $215.00.

Zoetis Trading Up 0.2 %

Shares of ZTS opened at $172.24 on Monday. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69. Zoetis has a 52-week low of $144.80 and a 52-week high of $200.53. The firm has a market cap of $77.71 billion, a price-to-earnings ratio of 32.38, a PEG ratio of 2.72 and a beta of 0.90. The business’s fifty day moving average is $169.48 and its 200-day moving average is $179.39.

Institutional Trading of Zoetis

Several institutional investors have recently added to or reduced their stakes in the stock. Atlantic Edge Private Wealth Management LLC boosted its stake in shares of Zoetis by 482.8% in the 4th quarter. Atlantic Edge Private Wealth Management LLC now owns 169 shares of the company’s stock valued at $28,000 after purchasing an additional 140 shares during the last quarter. Darwin Wealth Management LLC acquired a new position in Zoetis in the third quarter valued at $31,000. First Personal Financial Services bought a new stake in Zoetis during the third quarter valued at $33,000. Capital Performance Advisors LLP acquired a new stake in Zoetis during the 3rd quarter worth about $33,000. Finally, Dunhill Financial LLC raised its position in shares of Zoetis by 80.6% in the 3rd quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock worth $33,000 after acquiring an additional 75 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors.

Zoetis Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 4th. Shareholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This is an increase from Zoetis’s previous quarterly dividend of $0.43. This represents a $2.00 annualized dividend and a yield of 1.16%. Zoetis’s payout ratio is presently 37.59%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.